Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 6UNKNOWN 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Esophageal Neoplasms 3Uterine Cervical Neoplasms 1Esophageal Squamous Cell Carcinoma 1

Interventions

Paclitaxel 8nedaplatin 3TP protocol 3nimotuzumab 2S 1 (combination) 2Radiation 2Esophagectomy 2Cisplatin 2pegylated granulocyte colony-stimulating factor 1Radiotherapy, Adjuvant 1Platinum 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
UNKNOWN × Esophageal Neoplasms × nedaplatin × Clear all
NCT02279134 2020-04-03

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

ChineseAMS

Phase 2/3 Unknown
360 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

ChineseAMS

Phase 2 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02429622 2017-01-18

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

ChineseAMS

Phase 1/2 Completed
80 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡